On the premiere leveraged finance transaction on the Bulgarian market in 2017, we acted for all finance parties, including the Co-Arrangers (Rabobank Antwerp, BNP PARIBAS S.A. – Sofia Branch, UniCredit Bulbank AD and ING Bank N.V. – Sofia Branch), the Agent (Citibank Europe plc, UK Branch) and the Security Agent (Citibank N.A., London Branch) in relation to a EUR 550,000,000 multi facility loan made available to Huvepharma OOD and its affiliates in Bulgaria and abroad. The team was co-lead by our Managing Partner Georgi Spasov and counsel Nadia Hadjova, supported by Nayden, Peter and Irina. This is the fourth transaction that the highly experienced team is working on with Citibank since the initial syndication of the Huvepharma loan back in 2014. Huvepharma continues to outpace all expectations for its growth and has become one of the world’s largest and fast-growing global pharmaceutical companies with a focus on developing, manufacturing and marketing human and animal health products. The borrowers – part of the Huvepharma group will use the fresh funding (including a new Capex Facility and an Acquisition Facility) to fuel its global business expansion and refinance their existing indebtedness on more favorable terms. Contact us to understand more about our vast expertise on cross border lending.

Comments are closed.